Cephalothin
Back to searchMolecule Structure
Scientific Name
Cephalothin
Description of the Drug
Cefalotin is a broad-spectrum cephalosporin antibiotic used for the treatment of serious bacterial infections in various locations, such as the urinary tract, skin, bone, and lower respiratory tract.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00456
http://www.drugbank.ca/drugs/DB00456
Brand Name(s)
Not Available
Company Owner(s)
Glaxosmithkline, Abbott Laboratories Pharmaceutical Products Div, Abraxis Pharmaceutical Products, International Medication Systems Ltd, Eli Lilly And Co, Bristol Laboratories Inc Div Bristol Myers Co, Baxter Healthcare Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
| Atlas | cephalothin | ||||
| SureChEMBL | SCHEMBL2990 | SCHEMBL20477170 | |||
| PharmGKB | PA448886 | ||||
| Human Metabolome Database | HMDB0014599 | ||||
| DrugBank | DB00456 | ||||
| PubChem: Thomson Pharma | 16794138 | 14781066 | |||
| PubChem | 6024 | ||||
| Mcule | MCULE-4381582862 | ||||
| NMRShiftDB | 60022078 | ||||
| LINCS | LSM-15184 | ||||
| Nikkaji | J3.273E | ||||
| PDBe | CLS | ||||
| BindingDB | 82898 | ||||
| EPA CompTox Dashboard | DTXSID4022783 | ||||
| DrugCentral | 574 | ||||
| Brenda | 7661 | 3122 | 19396 | 3926 | 354 |
| ChemicalBook | CB52130371 | ||||
| Guide to Pharmacology | 8798 | ||||
| rxnorm | CEPHALOTHIN SODIUM | CEPHALOTHIN | |||
| KEGG Ligand | C07761 | ||||
| ChEBI | 124991 | ||||
| ZINC | ZINC000003830507 |
